Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Albumin-bound Paclitaxel plus S-1 in Advanced or Recurrent Gastric Adenocarcinoma
NCT03801668Phase 3Unknown
- Sponsor
- Huazhong University of Science and Technology
- Start
- Mar 2019
- Primary completion
- Dec 2022
- Modality
- Cytokines & Interferons, Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 3 trial of Paclitaxel Micelles for Injection in gastric adenocarcinoma, sponsored by Huazhong University of Science and Technology. Status: unknown.
02
Drugs
Paclitaxel Micelles for Injection
03
Conditions
gastric adenocarcinoma
Beyond the preview
Go deeper on NCT03801668.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03801668.